New York State Challenges the White House's Stance on Legal Cannabis

A New York family will go to court Wednesday to challenge the federal government, arguing that cannabis shouldn't be a Schedule 1 drug. Amanda Ostrowitz, co-founder and CEO of CannaRegs, says the case might not change the laws For full interview [click here](https://cheddar.com/videos/how-cannaregs-is-capitalizing-on-cannabis).

More In Business

Bristol Myers Squibb to Buy Cancer Drug Developer RayzeBio

Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.

Pizza Hut to Lay Off Over 1,200 Delivery Workers

Pizza Hut is set to lay off more than 1200 delivery workers in Los Angeles, Orange and Riverside counties in California.

Online Retailer Zulily Shuts Down

Online retailer Zulily said it's liquidating its assets and laying off hundreds of people.

New Drug May Help Children With Food Allergies

A new drug may provide relief to children against severe allergic reactions to peanut eggs, milk and other foods.

How to Make Your Resume Shine for 2024

Many people are thinking of their New Year's resolutions and resetting goals. Phyllis Ehrlich, career coach and president of Rocket Your Potential, joined Cheddar News to provide tips on how to polish up your resume for 2024 and explain why you should.

Stocks Mixed As S&P Nears Record Levels

Stocks were generally mixed after the opening bell as the S&P was nearing record levels.

Orlando Ranked Best City for NYE by Wallethub

Orlando Ranked Best City for NYE by Wallethub

E-Commerce Company Zulily Shuts Down

E-Commerce Company Zulily Shuts Down

Six-Year-Old Boy Traveling to Visit Grandma for Christmas Put on Wrong Spirit Flight

A 6-year-old boy who left on a flight for the Christmas holiday to visit his grandmother in southwest Florida instead was put on the wrong plane and ended up 160 miles away in Orlando, Florida.

Apple Seeks a Way in Court to Keep 2 of Its Best Watches on Shelves During Bitter Patent Dispute

Apple filed an emergency motion seeking court permission to begin selling two of its most popular watches again until a final decision on its broader appeal in a bitter patent dispute is decided.

Load More